<unk>  has been studied at "massive" dosages of up to 5,000 mg per day orally and 2,000 mg per day via intramuscular injection, without major tolerability or safety issues described. Overdose is not described in the Food and Drug Administration (FDA) product labels for injected<unk>  (Depo-Provera or Depo-SubQ Provera 104). In the FDA product label for oral<unk>  (Provera), it is stated that overdose of an estrogen and progestin may cause nausea and vomiting, breast tenderness, dizziness, abdominal pain, drowsiness, fatigue, and withdrawal bleeding. According to the label, treatment of overdose should consist of discontinuation of<unk>  therapy and symptomatic care.
Medroxyprogesterone acetate
Hydroxyprogesterone acetate
Desoxymethyltestosterone
Retroprogesterone
Gestodene
Lipoidal estradiol
Hydroxyprogesterone caproate
Cloxestradiol acetate